Clinical Trial Applications: Filter, Search, and view applications
# | Protocol No | Study Title | Investigator(s) & Site(s) | |
---|---|---|---|---|
36. |
ECCT/24/02/09 | pionERA This is a Phase III, randomized, open-label multicenter study that will evaluate the efficacy and safety of giredestrant compared with fulvestrant, both in combination with the investigator's choice of a CDK4/6 inhibitor (palbociclib, ribociclib or abemaciclib), in participants with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer who have developed resistance to adjuvant endocrine therapy. |
Principal Investigator(s) 1. Dr Sitna Ali Site(s) in Kenya University of Nairobi -Institute of Tropical and Infectious Diseases |
View |
37. |
ECCT/24/02/08 | H06_02TP A Phase 2 single-blind, randomized, controlled, single center study to assess the immunogenicity and safety of a 2-dose schedule with GVGH altSonflex1-2-3 vaccine in African infants (H06_02TP) |
Principal Investigator(s) 1. Josphat Kosgei Site(s) in Kenya KEMRI WRP CRC KERICHO |
View |
38. |
ECCT/24/02/07 | CO-SAM An adaptive multi-arm trial to improve clinical outcomes among children recovering from complicated severe acute malnutrition (CO-SAM) |
Principal Investigator(s) 1. Benson Singa Site(s) in Kenya 1. Homabay County Referral hospital (Homa Bay county) 2. Migori County Referral Hospital (Migori county) 3. Mbagathi County Referral Hospital (Nairobi City county) 4. Coast General Teaching and Referral Hospital (Mombasa county) |
View |
39. |
ECCT/24/02/06 | INAVO122 A phase III, multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of Inavolisib in combination with Phesgo versus placebo in combination with Phesgo as maintenance therapy after first line induction therapy in participants with PIK3CA‐mutated HER2‐positive locally advanced or metastatic breast cancer |
Principal Investigator(s) 1. Dr Sitna Ali Site(s) in Kenya University of Nairobi -Institute of Tropical and Infectious Diseases |
View |
40. |
ECCT/24/02/05 | Doxo-study Pharmacokinetic profiles for Doxorubicin among children with childhood cancer in Kenya. |
Principal Investigator(s) 1. Festus MUIGAI Njunguna Site(s) in Kenya MOI UNIVERSITY SCHOOL OF MEDICINE |
View |